Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/12/2022
Zai Lab Throws the Towel in CD47 Race and Decides to 'Deprioritize' I...
8/12/2022
Janssen Licences TESSA Technology from WuXi ATU
8/12/2022
NMPA Issues Announcement for Applicability of ICH Guidelines E8(R1) an...
8/12/2022
Drug R&D and Product Registration News Digest August 2022 (2)
8/12/2022
Recent Official and Executive Moves
8/11/2022
NMPA Orders to Strengthen Routine Regulation of Drug Clinical Trial In...
8/11/2022
Snapshot of BMI System Financial Performance in H1/2022
8/11/2022
Snapshot of Ten Best-Selling Drugs in Retail Pharmacies Q2/2022
8/11/2022
IQVIA: Overall Chinese Pharma Market Up 8.3% in 2021
8/11/2022
DuPont to Add Biopharma Silicone Tubing Plant in China
8/10/2022
Central Government Issues Notice on Strengthening Production, Reserve ...
8/10/2022
Chiesi Group Continues China Business Expansion: China Daily
8/9/2022
BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in ...
8/9/2022
NHSA Introduces the Uniform Coding Rules and Methods for BMI Designate...
8/9/2022
NHSA Cites Three Major Pharma Manufacturers for Artificially Hiking AP...
8/9/2022
CDE Solicits Comments on the Draft "Technical Guidelines for Implement...
8/9/2022
CDE Solicits Comments on the Draft "Technical Guidelines for Clinical ...
8/9/2022
CDE Solicits Comments on the Draft "Technical Guidelines for Benefit-R...
8/9/2022
Ophthalmology A New Opportunity for Biotechs in China (PharmaDJ)
8/9/2022
Analysis of Regulations for Approval of Digital Therapeutics in China
8/8/2022
Emerging Biopharma's Contribution to Innovation (IQVIA)
8/8/2022
Bayer's Xarelto Squeeze Rolls on As Cancer Newcomer Nubeqa Gains Steam
8/8/2022
Hansoh and TiumBio Enter $164M Licensing Pact for TU2670 in China
8/8/2022
AstraZeneca and Wuxi Biologics Tie Up to Make Preventive Covid-19 Jab ...
8/8/2022
Grand Pharma and XELTIS Enter Strategic Partnership for Endogenous Tis...
8/5/2022
CNIPA Rules In Favor of Boehringer in First Important Patent Infringem...
8/5/2022
More Than 30 Chinese Health Official Investigated/Prosecuted for Corru...
8/5/2022
Recent Executive Moves
8/5/2022
Drug R&D and Product Registration News Digest August 2022 (1)
8/5/2022
Bird's Eye View of Chinese Pharma Now: A Mixed Bag of Mostly Negative ...
Page:
75
/
719
Total number of articles:
21546
:
[First]
[<<]
[73]
[74]
[75]
[76]
[77]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit